NIMENRIX meningococcal (Groups A, C, W-135, Y) polysaccharide tetanus toxoid conjugate vaccine injection vial and diluent syringe

产品概览

About NIMENRIX meningococcal (Groups A, C, W-135, Y) polysaccharide tetanus toxoid conjugate vaccine injection vial and diluent syringe

NIMENRIX meningococcal (Groups A, C, W-135, Y) polysaccharide tetanus toxoid conjugate vaccine injection vial and diluent syringe is a prescription medicine designed to provide active immunization against invasive meningococcal disease. This product is supplied as a powder in a glass vial that must be reconstituted with the provided diluent in a pre-filled syringe before administration. It is indicated for individuals across a broad age range to help the immune system develop protection against specific strains of Neisseria meningitidis bacteria. By utilizing a conjugate technology, the vaccine helps the body recognize and respond to the bacterial polysaccharides associated with these four distinct serogroups.

Key Benefits & Uses

• Provides active immunization against meningococcal groups A, C, W-135, and Y.
• Utilizes tetanus toxoid as a carrier protein to enhance the immune response.
• Supplied as a convenient kit containing both the vaccine powder and the necessary diluent for reconstitution.

Active Ingredient & Action

The active components of this vaccine include meningococcal polysaccharide group A, group C, group W-135, and group Y, all conjugated to a tetanus toxoid protein. This conjugation process is intended to improve the immunogenicity of the polysaccharides, allowing the body to produce protective antibodies against these specific bacterial groups.

Important Notes

This medicine must be administered by a qualified healthcare professional. Always consult the full product monograph for specific dosage schedules, contraindications, and storage requirements. Ensure the reconstituted solution is clear and free of particulate matter before injection.